回复：肥厚型心肌病中的心房颤动 - Suppr

Suppr

超能文献

Reply: Atrial Fibrillation in Hypertrophic Cardiomyopathy.

作者信息

Maron Martin S, Udelson James E, Rowin Ethan J, Maron Barry J

出版信息

JACC Heart Fail. 2018 Sep;6(9):807-808. doi: 10.1016/j.jchf.2018.06.009.

DOI:10.1016/j.jchf.2018.06.009

PMID:30166029

Abstract

摘要

相似文献

Reply: Atrial Fibrillation in Hypertrophic Cardiomyopathy.回复：肥厚型心肌病中的心房颤动

JACC Heart Fail. 2018 Sep;6(9):807-808. doi: 10.1016/j.jchf.2018.06.009.

Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中的心房颤动

JACC Heart Fail. 2018 Sep;6(9):807. doi: 10.1016/j.jchf.2018.05.013.

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者行心肌切除术同期行房颤消融术。

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.

Atrial fibrillation in hypertrophic cardiomyopathy: another indication for circumferential pulmonary vein ablation?肥厚型心肌病中的心房颤动：环肺静脉消融的另一适应证？

Acta Cardiol. 2006 Apr;61(2):193-6. doi: 10.2143/AC.61.2.2014334.

Evolving indications for permanent pacemakers.永久性起搏器的适应证演变

Ann Intern Med. 2001 Jun 19;134(12):1130-41. doi: 10.7326/0003-4819-134-12-200106190-00014.

Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.回复：在肥厚型心肌病中使用肾素-血管紧张素-醛固酮系统阻滞剂预防心房颤动之前，还需要进一步研究。

Heart. 2018 Dec;104(23):1985-1986. doi: 10.1136/heartjnl-2018-314000.

Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).肥厚型心肌病患者左心房大小的预后意义（来自意大利肥厚型心肌病注册研究）

Am J Cardiol. 2006 Oct 1;98(7):960-5. doi: 10.1016/j.amjcard.2006.05.013. Epub 2006 Aug 14.

[Hypertrophic obstructive cardiomyopathy. (Idiopathic hypertrophic subvalvular aortic stenosis)].肥厚性梗阻性心肌病。（特发性肥厚性主动脉瓣下狭窄）

Med Welt. 1979 Jun 22;30(25):985-8.

Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者心房颤动的机制及血栓栓塞发生率增加

Jpn Circ J. 1995 Jun;59(6):329-36. doi: 10.1253/jcj.59.329.

Results from the Kochi RYOMA Study. Atrial fibrillation is a major risk of morbidity in patients with hypertrophic cardiomyopathy.高知龙马研究结果。心房颤动是肥厚型心肌病患者发病的主要风险。

Circ J. 2009 Sep;73(9):1589-90. doi: 10.1253/circj.cj-09-0433.

引用本文的文献

Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?心律失常与猝死：肥厚型心肌病有哪些新进展？

Card Fail Rev. 2025 Apr 1;11:e08. doi: 10.15420/cfr.2024.38. eCollection 2025.

Implementation of a Sudden Cardiac Death Risk Prediction Tool in Clinical Practice Through Electronic Health Records (INSERT-HCM Study Design).通过电子健康记录在临床实践中实施心脏性猝死风险预测工具（INSERT-HCM研究设计）。

CJC Open. 2024 Oct 9;7(1):46-52. doi: 10.1016/j.cjco.2024.10.002. eCollection 2025 Jan.

Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registries.了解肥厚型心肌病患者心房颤动和中风的发生率：来自丹麦全国登记处的见解。

Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae177.

Transapical intramyocardial septal microwave ablation in treatment of hypertrophic obstructive cardiomyopathy: 12-month outcomes of a swine model.经心尖心肌内室间隔微波消融治疗肥厚型梗阻性心肌病: 猪模型的 12 个月结果。

J Cardiothorac Surg. 2024 Apr 13;19(1):205. doi: 10.1186/s13019-024-02677-z.

Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.心肌病中的Krüpple样因子：新兴角色与治疗机遇

Front Cardiovasc Med. 2024 Mar 7;11:1342173. doi: 10.3389/fcvm.2024.1342173. eCollection 2024.

Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review.印度肥厚型心肌病患者的肌节基因变异：范围综述。

Indian J Med Res. 2023 Aug;158(2):119-135. doi: 10.4103/ijmr.ijmr_3567_21.

Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort study.丹麦肥厚型心肌病的时间趋势：一项全国性回顾性队列研究。

BMJ Open. 2023 Sep 4;13(9):e074010. doi: 10.1136/bmjopen-2023-074010.

Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy.EXPLORER-CN 研究的设计与原理：一项评价马西替坦在有症状梗阻性肥厚型心肌病中国成年患者中的疗效和安全性的 III 期、随机、双盲、安慰剂对照临床研究。

BMJ Open. 2023 Jun 19;13(6):e071473. doi: 10.1136/bmjopen-2022-071473.

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM).鉴定导致肥厚型心肌病（HCM）的潜在miRNA-mRNA调控网络。

Front Cardiovasc Med. 2021 May 31;8:660372. doi: 10.3389/fcvm.2021.660372. eCollection 2021.

Hypertrophic cardiomyopathy.肥厚型心肌病

Int J Cardiol Heart Vasc. 2020 Mar 25;27:100503. doi: 10.1016/j.ijcha.2020.100503. eCollection 2020 Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验